ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

NCT02672436 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot
Foot Ulcer
Diabetes Mellitus
Wounds

Interventions

DRUG: ENERGI-F703
DRUG: ENERGI-F703 matched vehicle

Sponsor

Energenesis Biomedical Co., Ltd.

Collaborators

[object Object]